<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38953987</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0878</ISSN><JournalIssue CitedMedium="Internet"><Volume>397</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cell and tissue research</Title><ISOAbbreviation>Cell Tissue Res</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2-related peptides induce endothelial-to-mesenchymal transition in endothelial capillary cells derived from different body districts: focus on membrane (M) protein.</ArticleTitle><Pagination><StartPage>241</StartPage><EndPage>262</EndPage><MedlinePgn>241-262</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00441-024-03900-y</ELocationID><Abstract><AbstractText>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the COVID-19, may lead to multiple organ dysfunctions and long-term complications. The induction of microvascular dysfunction is regarded as a main player in these pathological processes. To investigate the possible impact of SARS-CoV-2-induced endothelial-to-mesenchymal transition (EndMT) on fibrosis in "long-COVID" syndrome, we used primary cultures of human microvascular cells derived from the lungs, as the main infection target, compared to cells derived from different organs (dermis, heart, kidney, liver, brain) and to the HUVEC cell line. To mimic the virus action, we used mixed SARS-CoV-2 peptide fragments (PepTivator<sup>&#xae;</sup>) of spike (S), nucleocapsid (N), and membrane (M) proteins. TGF&#x3b2;2 and cytokine mix (IL-1&#x3b2;, IL-6, TNF&#x3b1;) were used as positive controls. The percentage of cells positive to mesenchymal and endothelial markers was quantified by high content screening. We demonstrated that S+N+M mix induces irreversible EndMT in all analyzed endothelial cells via the TGF&#x3b2; pathway, as demonstrated by ApoA1 treatment. We then tested the contribution of single peptides in lung and brain cells, demonstrating that EndMT is triggered by M peptide. This was confirmed by transfection experiment, inducing the endogenous expression of the glycoprotein M in lung-derived cells. In conclusion, we demonstrated that SARS-CoV-2 peptides induce EndMT in microvascular endothelial cells from multiple body districts. The different peptides play different roles in the induction and maintenance of the virus-mediated effects, which are organ-specific. These results corroborate the hypothesis of the SARS-CoV-2-mediated microvascular damage underlying the multiple organ dysfunctions and the long-COVID syndrome.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baldassarro</LastName><ForeName>Vito Antonio</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Ozzano dell'Emilia, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdepartmental Centre for Industrial Research in Health Sciences and Technology ICIR-HST, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alastra</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Ozzano dell'Emilia, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cescatti</LastName><ForeName>Maura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRET Foundation, Ozzano Emilia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quadalti</LastName><ForeName>Corinne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzini</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Ozzano dell'Emilia, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdepartmental Centre for Industrial Research in Health Sciences and Technology ICIR-HST, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giardino</LastName><ForeName>Luciana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Ozzano dell'Emilia, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdepartmental Centre for Industrial Research in Health Sciences and Technology ICIR-HST, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calz&#xe0;</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4426-8477</Identifier><AffiliationInfo><Affiliation>Interdepartmental Centre for Industrial Research in Health Sciences and Technology ICIR-HST, University of Bologna, Bologna, Italy. laura.calza@unibo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy. laura.calza@unibo.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FISR2020IP_01778</GrantID><Agency>Ministero dell'Istruzione, dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Cell Tissue Res</MedlineTA><NlmUniqueID>0417625</NlmUniqueID><ISSNLinking>0302-766X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086862">Coronavirus M Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="Y">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058750" MajorTopicYN="Y">Epithelial-Mesenchymal Transition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086862" MajorTopicYN="N">Coronavirus M Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061307" MajorTopicYN="N">Human Umbilical Vein Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endothelial microvessel cells</Keyword><Keyword MajorTopicYN="N">Endothelial-to-mesenchymal transition</Keyword><Keyword MajorTopicYN="N">Fibrosis</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>4</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>14</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38953987</ArticleId><ArticleId IdType="doi">10.1007/s00441-024-03900-y</ArticleId><ArticleId IdType="pii">10.1007/s00441-024-03900-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed SF, Quadeer AA, McKay MR (2020) Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. https://doi.org/10.3390/v12030254</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12030254</ArticleId><ArticleId IdType="pubmed">32933112</ArticleId><ArticleId IdType="pmc">7551587</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek AR, Lee JM, Seo HJ et al (2016) Apolipoprotein A1 inhibits tgf-&#x3b2;1-induced epithelial-to-mesenchymal transition of alveolar epithelial cells. Tuberc Respir Dis (seoul) 79:143&#x2013;152. https://doi.org/10.4046/trd.2016.79.3.143</Citation><ArticleIdList><ArticleId IdType="doi">10.4046/trd.2016.79.3.143</ArticleId><ArticleId IdType="pubmed">27433174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahram Yazdroudi F, Malek A (2023) Optimal controlling of anti-TGF-&#x3b2; and anti-PDGF medicines for preventing pulmonary fibrosis. Sci Rep 13:15073. https://doi.org/10.1038/s41598-023-41294-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-41294-z</ArticleId><ArticleId IdType="pubmed">37699920</ArticleId><ArticleId IdType="pmc">10497573</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldassarro VA (2021) High-content screening differentiation and maturation analysis of fetal and adult neural stem cell-derived oligodendrocyte precursor cell cultures. J vis Exp 2021:e61988. https://doi.org/10.3791/61988</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/61988</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskar S, Sinha A, Banach M et al (2020) Cytokine storm in COVID-19&#x2014;immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM Consortium Position Paper. Front Immunol. https://doi.org/10.3389/fimmu.2020.01648</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01648</ArticleId><ArticleId IdType="pubmed">32754159</ArticleId><ArticleId IdType="pmc">7365905</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Mamun A, Dominic A, Le NT (2021) SARS-CoV-2 mediated endothelial dysfunction: the potential role of chronic oxidative stress. Front Physiol 11:1&#x2013;27. https://doi.org/10.3389/fphys.2020.605908</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.605908</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J et al (2021) Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights From TUN-EndCOV Study. Front Cardiovasc Med 8:1&#x2013;8. https://doi.org/10.3389/fcvm.2021.745758</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciszewski WM, Wawro ME, Sacewicz-hofman I, Sobierajska K (2021) Cytoskeleton reorganization in endmt&#x2014;the role in cancer and fibrotic diseases. Int J Mol Sci. https://doi.org/10.3390/ijms222111607</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111607</ArticleId><ArticleId IdType="pubmed">34947988</ArticleId><ArticleId IdType="pmc">8708659</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejana E, Hirschi KK, Simons M (2017) The molecular basis of endothelial cell plasticity. Nat Commun. https://doi.org/10.1038/ncomms14361</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14361</ArticleId><ArticleId IdType="pubmed">28181491</ArticleId><ArticleId IdType="pmc">5309780</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle DM, Kim-Schulze S, Huang H-H et al (2020) An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med 26:1636&#x2013;1643. https://doi.org/10.1038/s41591-020-1051-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId><ArticleId IdType="pmc">7869028</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey TM, Ziegler CGK, Heimberg G et al (2021) COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595:107&#x2013;113. https://doi.org/10.1038/s41586-021-03570-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId><ArticleId IdType="pmc">8919505</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY (2022) Long-term complications of COVID-19. Am J Physiol - Cell Physiol 322:C1&#x2013;C11. https://doi.org/10.1152/AJPCELL.00375.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/AJPCELL.00375.2021</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Falleni M, Tosi D, Savi F et al (2021) Endothelial-mesenchymal transition in COVID-19 lung lesions. Pathol Res Pract 221:153419. https://doi.org/10.1016/j.prp.2021.153419</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2021.153419</ArticleId><ArticleId IdType="pubmed">33857718</ArticleId><ArticleId IdType="pmc">7997691</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J, Zhang J, Jackson AO et al (2017) Apolipoprotein A1 inhibits the TGF-&#x3b2;1-induced endothelial-to-mesenchymal transition of human coronary artery endothelial cells. Cardiol 137:179&#x2013;187. https://doi.org/10.1159/000464321</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000464321</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaifel A, Kwok B, Ko J et al (2022) Pulmonary pathology of end-stage COVID-19 disease in explanted lungs and outcomes after lung transplantation. Am J Clin Pathol 157:908&#x2013;926. https://doi.org/10.1093/ajcp/aqab208</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqab208</ArticleId><ArticleId IdType="pubmed">34999755</ArticleId><ArticleId IdType="pmc">8755396</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazzinelli-Guimaraes PH, Sanku G, Sette A et al (2022) Antigenic determinants of SARS-CoV-2-specific CD4+ T cell lines reveals M protein-driven dysregulation of interferon signaling. Front Immunol 13:1&#x2013;10. https://doi.org/10.3389/fimmu.2022.883159</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.883159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazavia&#xa0;A, Ganji A, Keshavarzian N, Rabiemajd S, Mosayebi G&#xa0;(2021) Cytokine profile and disease severity in patients with COVID-19. Cytokine 137:155323. https://doi.org/10.1016/j.cyto.2020.155323</Citation></Reference><Reference><Citation>Hurtado-Tamayo J, Requena-Platek R, Enjuanes L et al (2023) Contribution to pathogenesis of accessory proteins of deadly human coronaviruses. Front Cell Infect Microbiol 13:1&#x2013;16. https://doi.org/10.3389/fcimb.2023.1166839</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1166839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyun SW, Liu A, Liu Z et al (2017) As human lung microvascular endothelia achieve confluence, src family kinases are activated, and tyrosine-phosphorylated p120 catenin physically couples NEU1 sialidase to CD31. Cell Signal 35:1&#x2013;15. https://doi.org/10.1016/j.cellsig.2017.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2017.03.014</ArticleId><ArticleId IdType="pubmed">28343945</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson AO, Zhang J, Jiang Z, Yin K (2017) Endothelial-to-mesenchymal transition: a novel therapeutic target for cardiovascular diseases. Trends Cardiovasc Med 27:383&#x2013;393. https://doi.org/10.1016/j.tcm.2017.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2017.03.003</ArticleId><ArticleId IdType="pubmed">28438397</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Ji W, Yang H et al (2020) Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther 5:1&#x2013;13. https://doi.org/10.1038/s41392-020-00454-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00454-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamoorthi MK, Thandavarayan RA, Youker KA, Bhimaraj A (2022) An in vitro platform to study reversible endothelial-to-mesenchymal transition. Front Pharmacol 13:1&#x2013;10. https://doi.org/10.3389/fphar.2022.912660</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.912660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamouille S, Xu J, Derynck R (2014) Fakultas Psikologi Dan Sosial Budaya Universitas Islam Indonesia Yogyakarta. Nat Rev Mol Cell Biol 15:178&#x2013;196. https://doi.org/10.1038/nrm3758.Molecular</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3758.Molecular</ArticleId><ArticleId IdType="pubmed">24556840</ArticleId><ArticleId IdType="pmc">4240281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S, Ye Q, Singh D et al (2021) The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein. Nat Commun. https://doi.org/10.1038/s41467-020-20768-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20768-y</ArticleId><ArticleId IdType="pubmed">34921143</ArticleId><ArticleId IdType="pmc">8683505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, van der Zon G, Gon&#xe7;alves MAFV et al (2021) TGF-&#x3b2;-induced endothelial to mesenchymal transition is determined by a balance between SNAIL and ID factors. Front Cell Dev Biol 9:1&#x2013;20. https://doi.org/10.3389/fcell.2021.616610</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.616610</ArticleId></ArticleIdList></Reference><Reference><Citation>Melms JC, Biermann J, Huang H et al (2021) A molecular single-cell lung atlas of lethal COVID-19. Nature 595:114&#x2013;119. https://doi.org/10.1038/s41586-021-03569-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03569-1</ArticleId><ArticleId IdType="pubmed">33915568</ArticleId><ArticleId IdType="pmc">8814825</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhl L, He L, Sun Y et al (2022) The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: implications for COVID-19 vascular research. Stem Cell Reports 17:1089&#x2013;1104. https://doi.org/10.1016/j.stemcr.2022.03.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.03.016</ArticleId><ArticleId IdType="pubmed">35452595</ArticleId><ArticleId IdType="pmc">9022216</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe4;gele MP, Haubner B, Tanner FC et al (2020) Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis 314:58&#x2013;62. https://doi.org/10.1016/j.atherosclerosis.2020.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2020.10.014</ArticleId><ArticleId IdType="pubmed">33161318</ArticleId><ArticleId IdType="pmc">7554490</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HNT, Kawahara M, Vuong CK et al (2022) SARS-CoV-2 M protein facilitates malignant transformation of breast cancer cells. Front Oncol 12:1&#x2013;13. https://doi.org/10.3389/fonc.2022.923467</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.923467</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC et al (2023) A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol 64:66&#x2013;74. https://doi.org/10.1007/s12016-021-08848-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelisek J, Reutersberg B, Greber UF, Zimmermann A (2022) Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs. Clin Sci 136:1571&#x2013;1590. https://doi.org/10.1042/CS20220235</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20220235</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez L, Mu&#xf1;oz-Durango N, Riedel CA et al (2017) Endothelial-to-mesenchymal transition: cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions. Cytokine Growth Factor Rev 33:41&#x2013;54. https://doi.org/10.1016/j.cytogfr.2016.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2016.09.002</ArticleId><ArticleId IdType="pubmed">27692608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi P, Zeng Z, Zeng L et al (2023) Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition. Front Pharmacol 14:1&#x2013;17. https://doi.org/10.3389/fphar.2023.1218059</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1218059</ArticleId></ArticleIdList></Reference><Reference><Citation>Piera-Velazquez S, Jimenez SA (2019) Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases. Physiol Rev 99:1281&#x2013;1324. https://doi.org/10.1152/physrev.00021.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00021.2018</ArticleId><ArticleId IdType="pubmed">30864875</ArticleId><ArticleId IdType="pmc">6734087</ArticleId></ArticleIdList></Reference><Reference><Citation>Piera-Velazquez S, Li Z, Jimenez SA (2011) Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 179:1074&#x2013;1080. https://doi.org/10.1016/j.ajpath.2011.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2011.06.001</ArticleId><ArticleId IdType="pubmed">21763673</ArticleId><ArticleId IdType="pmc">3157273</ArticleId></ArticleIdList></Reference><Reference><Citation>Piera-Velazquez S, Mendoza FA, Jimenez SA (2016) Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of human fibrotic diseases. J Clin Med 5:1&#x2013;22. https://doi.org/10.3390/jcm5040045</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm5040045</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad M, Leon M, Lerman LO, Lerman A (2021) Viral endothelial dysfunction: a unifying mechanism for COVID-19. Mayo Clin Proc 96:3099&#x2013;3108. https://doi.org/10.1016/j.mayocp.2021.06.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.06.027</ArticleId><ArticleId IdType="pubmed">34863398</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Wang A, Fang Y et al (2021) SARS-CoV-2 membrane glycoprotein M triggers apoptosis with the assistance of nucleocapsid protein N in cells. Front Cell Infect Microbiol 11:1&#x2013;12. https://doi.org/10.3389/fcimb.2021.706252</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.706252</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbineni H, Verma A, Somanath PR (2018) Isoform-specific effects of transforming growth factor &#x3b2; on endothelial-to-mesenchymal transition. J Cell Physiol 233:8418&#x2013;8428. https://doi.org/10.1002/jcp.26801</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26801</ArticleId><ArticleId IdType="pubmed">29856065</ArticleId><ArticleId IdType="pmc">6415927</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez B, Li L, Dulong J et al (2019) Impact of human dermal microvascular endothelial cells on primary dermal fibroblasts in response to inflammatory stress. Front Cell Dev Biol 7:1&#x2013;10. https://doi.org/10.3389/fcell.2019.00044</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00044</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi N, Wang Z, Zhu H et al (2022) Research progress on drugs targeting the TGF-&#x3b2; signaling pathway in fibrotic diseases. Immunol Res 70:276. https://doi.org/10.1007/s12026-022-09267-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-022-09267-y</ArticleId><ArticleId IdType="pubmed">35147920</ArticleId><ArticleId IdType="pmc">9197809</ArticleId></ArticleIdList></Reference><Reference><Citation>Six I, Guillaume N, Jacob V et al (2022) The endothelium and COVID-19: an increasingly clear link brief title: endotheliopathy in COVID-19. Int J Mol Sci. https://doi.org/10.3390/ijms23116196</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23116196</ArticleId><ArticleId IdType="pubmed">36430871</ArticleId><ArticleId IdType="pmc">9696964</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Nkennor B, Mastikhina O et al (2020) Endothelium-mediated contributions to fibrosis. Semin Cell Dev Biol 101:78&#x2013;86. https://doi.org/10.1016/j.semcdb.2019.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.10.015</ArticleId><ArticleId IdType="pubmed">31791693</ArticleId></ArticleIdList></Reference><Reference><Citation>Thieme CJ, Anft M, Paniskaki K et al (2020) Robust T cell response toward spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients. Cell Reports Med 1:100092. https://doi.org/10.1016/j.xcrm.2020.100092</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100092</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukui T, Sun KH, Wetter JB et al (2020) Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat Commun 11:1&#x2013;16. https://doi.org/10.1038/s41467-020-15647-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15647-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417&#x2013;1418. https://doi.org/10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId><ArticleId IdType="pmc">7172722</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz de Paula CB, Nagashima S, Liberalesso V et al (2021) COVID-19: immunohistochemical analysis of TGF-&#x3b2; signaling pathways in pulmonary fibrosis. Int J Mol Sci. https://doi.org/10.3390/ijms23010168</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23010168</ArticleId><ArticleId IdType="pubmed">35008594</ArticleId><ArticleId IdType="pmc">8745764</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Tan X, Hulshoff MS et al (2016) Hypoxia-induced endothelial-mesenchymal transition is associated with RASAL1 promoter hypermethylation in human coronary endothelial cells. FEBS Lett 590:1222&#x2013;1233. https://doi.org/10.1002/1873-3468.12158</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12158</ArticleId><ArticleId IdType="pubmed">27012941</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wu Y, Meng X et al (2022) SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK. Cell Death Differ 29:1395&#x2013;1408. https://doi.org/10.1038/s41418-022-00928-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-00928-x</ArticleId><ArticleId IdType="pubmed">35022571</ArticleId><ArticleId IdType="pmc">8752586</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimatsu Y, Watabe T (2022) Emerging roles of inflammation-mediated endothelial&#x2013;mesenchymal transition in health and disease. Inflamm Regen. https://doi.org/10.1186/s41232-021-00186-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41232-021-00186-3</ArticleId><ArticleId IdType="pubmed">36329556</ArticleId><ArticleId IdType="pmc">9632047</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani Rarani F, Zamani Rarani M, Hamblin MR et al (2022) Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions. Cell Mol Biol Lett. https://doi.org/10.1186/S11658-022-00363-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S11658-022-00363-3</ArticleId><ArticleId IdType="pubmed">35907817</ArticleId><ArticleId IdType="pmc">9338538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Gao S, White Z et al (2022a) Single-cell transcriptomic profiling of lung endothelial cells identifies dynamic inflammatory and regenerative subpopulations. JCI Insight. https://doi.org/10.1172/jci.insight.158079</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.158079</ArticleId><ArticleId IdType="pubmed">36509291</ArticleId><ArticleId IdType="pmc">9869977</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Nomura N, Muramoto Y et al (2022b) Structure of SARS-CoV-2 membrane protein essential for virus assembly. Nat Commun 13:1&#x2013;7. https://doi.org/10.1038/s41467-022-32019-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32019-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Zhuang MW, Han L et al (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. Signal Transduct Target Ther. https://doi.org/10.1038/s41392-020-00438-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00438-7</ArticleId><ArticleId IdType="pubmed">33372174</ArticleId><ArticleId IdType="pmc">7768267</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>